Understanding fragility fracture patients’ decision-making process regarding bisphosphonate treatment

Osteoporosis International

Volumn 28, Issue 1, 2017, Pages 219-229

  Wozniak, L A ^a   Johnson, J A ^a   McAlister, F A ^a   Beaupre, L A ^a   Bellerose, D ^a   Rowe, B H ^a   Majumdar, S R ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Adherence; Fragility fractures; Grounded theory; Osteoporosis; Persistence; Treatment

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT;

ADULT; ARTICLE; BONE DENSITOMETRY; CLINICAL ARTICLE; DISEASE SEVERITY; DISTAL RADIUS FRACTURE; FEMALE; FRAGILITY FRACTURE; GROUNDED THEORY; HEALTH CARE PERSONNEL; HUMAN; INTERVIEW; MALE; PATIENT DECISION MAKING; PRIORITY JOURNAL; PROXIMAL HUMERUS FRACTURE; QUALITATIVE ANALYSIS; TREATMENT OUTCOME; AGED; ALBERTA; ATTITUDE TO HEALTH; COMPLICATION; DECISION MAKING; MEDICATION COMPLIANCE; MIDDLE AGED; OSTEOPOROSIS; PROCEDURES; PSYCHOLOGY; QUALITATIVE RESEARCH; RISK ASSESSMENT; SECONDARY PREVENTION;

AGED; ALBERTA; ATTITUDE TO HEALTH; BONE DENSITY CONSERVATION AGENTS; DECISION MAKING; DIPHOSPHONATES; FEMALE; GROUNDED THEORY; HUMANS; INTERVIEWS AS TOPIC; MALE; MEDICATION ADHERENCE; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; QUALITATIVE RESEARCH; RISK ASSESSMENT; SECONDARY PREVENTION;

EID: 84978807228     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-016-3693-5     Document Type: Article

References (52)

1. Little EA, Eccles MP (2010) A systematic review of the effectiveness of interventions to improve post-fracture investigation and management of patients at risk of osteoporosis. IS 5:80–97. doi:10.1186/1748-5908-5-80
2. Sujic R, Gignac MA, Cockerill R, Beaton DE (2011) A review of patient-centred post-fracture interventions in the context of theories of health behaviour change. Osteoporos Int 22(8):2213–2224. doi:10.1007/s00198-010-1521-x
3. Andrade SE, Majumdar SR, Chan KA, Buist DS, Go AS, Goodman M, Smith DH, Platt R, Gurwitz JH (2003) Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. Arch Intern Med 163(17):2052–2057. doi:10.1001/archinte.163.17.2052
4. MacLean C, Newberry S, Maglione M, McMahon M, Ranganath V, Suttorp M, Mojica W, Timmer M, Alexander A, McNamara M, Desai SB, Zhou A, Chen S, Carter J, Tringale C, Valentine D, Johnsen B, Grossman J (2008) Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis. Ann Intern Med 148(3):197–213
5. Bolland MJ, Grey AB, Gamble GD, Reid IR (2010) Effect of osteoporosis treatment on mortality: a meta-analysis. J Clin Endocrinol Metab 95(3):1174–1181. doi:10.1210/jc.2009-0852
6. Beaton DE, Sujic R, McIlroy Beaton K, Sale J, Elliot-Gibson V, Bogoch ER (2012) Patient perceptions of the path to osteoporosis care following a fragility fracture. Qual Health Res 22(12):1647–1658. doi:10.1177/1049732312457467
7. Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R (2014) Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int 25(10):2359–2381. doi:10.1007/s00198-014-2794-2
8. International Osteoporosis Foundation (2015) Guidelines. http://www.iofbonehealth.org/content-type-semantic-meta-tags/guidelines. Accessed 20 June 2016
9. Papaioannou A, Morin S, Cheung AM, Atkinson S, Brown JP, Feldman S, Hanley DA, Hodsman A, Jamal SA, Kaiser SM, Kvern B, Siminoski K, Leslie WD (2010) 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ 182(17):1864–1873. doi:10.1503/cmaj.100771
10. Reynolds K, Muntner P, Cheetham TC, Harrison TN, Morisky DE, Silverman S, Gold DT, Vansomphone SS, Wei R, O’Malley CD (2013) Primary non-adherence to bisphosphonates in an integrated healthcare setting. Osteoporos Int 24(9):2509–2517. doi:10.1007/s00198-013-2326-5
11. Reginster JY, Rabenda V (2006) Adherence to anti-osteoporotic treatment: does it really matter? Futur Rheumatol 1(1):37–40
12. Edwards BJ, Bunta AD, Madison LD, DeSantis A, Ramsey-Goldman R, Taft L, Wilson C, Moinfar M (2005) An osteoporosis and fracture intervention program increases the diagnosis and treatment for osteoporosis for patients with minimal trauma fractures. Jt Comm J Qual Patient Saf/Jt Comm Resour 31(5):267–274
13. Majumdar SR, Johnson JA, Lier DA, Russell AS, Hanley DA, Blitz S, Steiner IP, Maksymowych WP, Morrish DW, Holroyd BR, Rowe BH (2007) Persistence, reproducibility, and cost-effectiveness of an intervention to improve the quality of osteoporosis care after a fracture of the wrist: results of a controlled trial. Osteoporos Int 18(3):261–270. doi:10.1007/s00198-006-0248-1
14. Whitlock EP, Orleans CT, Pender N, Allan J (2002) Evaluating primary care behavioral counseling interventions: an evidence-based approach. Am J Prev Med 22(4):267–284
15. Klop C, Welsing PM, Elders PJ, Overbeek JA, Souverein PC, Burden AM, van Onzenoort HA, Leufkens HG, Bijlsma JW, de Vries F (2015) Long-term persistence with anti-osteoporosis drugs after fracture. Osteoporos Int 26(6):1831–1840. doi:10.1007/s00198-015-3084-3
16. Majumdar SR, McAlister FA, Johnson JA, Weir DL, Bellerose D, Hanley DA, Russell AS, Rowe BH (2014) Critical impact of patient knowledge and bone density testing on starting osteoporosis treatment after fragility fracture: secondary analyses from two controlled trials. Osteoporos Int 25(9):2173–2179. doi:10.1007/s00198-014-2728-z
17. Sale JE, Beaton DE, Bogoch ER, Elliot-Gibson V, Frankel L (2010) The BMD muddle: the disconnect between bone densitometry results and perception of bone health. J Clin Densitom 13(4):370–378. doi:10.1016/j.jocd.2010.07.007
18. Majumdar SR, Johnson JA, Bellerose D, McAlister FA, Russell AS, Hanley DA, Garg S, Lier DA, Maksymowych WP, Morrish DW, Rowe BH (2011) Nurse case-manager vs multifaceted intervention to improve quality of osteoporosis care after wrist fracture: randomized controlled pilot study. Osteoporos Int 22(1):223–230. doi:10.1007/s00198-010-1212-7
19. Beaton DE, Dyer S, Jiang D, Sujic R, Slater M, Sale JE, Bogoch ER (2014) Factors influencing the pharmacological management of osteoporosis after fragility fracture: results from the Ontario Osteoporosis Strategy’s fracture clinic screening program. Osteoporos Int 25(1):289–296. doi:10.1007/s00198-013-2430-6
20. Brookhart MA, Avorn J, Katz JN, Finkelstein JS, Arnold M, Polinski JM, Patrick AR, Mogun H, Solmon DH (2007) Gaps in treatment among users of osteoporosis medications: the dynamics of noncompliance. Am J Med 120(3):251–256. doi:10.1016/j.amjmed.2006.03.029
21. Yood RA, Mazor KM, Andrade SE, Emani S, Chan W, Kahler KH (2008) Patient decision to initiate therapy for osteoporosis: the influence of knowledge and beliefs. J Gen Intern Med 23(11):1815–1821. doi:10.1007/s11606-008-0772-0
22. Corbin J, Strauss A (2008) Basics of qualitative research: techniques and procedures for developing grounded theory, 3rd edn. Sage Publications, Los Angeles, CA
23. Siris ES, Adler R, Bilezikian J, Bolognese M, Dawson-Hughes B, Favus MJ, Harris ST, Jan de Beur SM, Khosla S, Lane NE, Lindsay R, Nana AD, Orwoll ES, Saag K, Silverman S, Watts NB (2014) The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group. Osteoporos Int 25(5):1439–1443. doi:10.1007/s00198-014-2655-z
24. Mayan MJ (2009) Essentials of qualitative inquiry. Left Coast Press, Walnut Creek, California, Qualitative Essentials
25. Charmaz K (2006) Constructing grounded theory: a practical guide through qualitative analysis. Sage, London
26. Morse JM, Stern P, Corbin JM, Charmaz KC, Bowers B, Clarke AE (2008) Developing grounded theory. Left Coast Press, Walnut Creek, CA
27. Morse JM (2000) Determining sample size. Qual Health Res 10(1):3–5. doi:10.1177/104973200129118183
28. Morse JM (1994) Designing qualitative research. In: Denzin NK, Lincoln YS (eds) The handbook of qualitative research. Sage Thousand Oaks, California, pp 220–235
29. Morse JM, Barret M, Mayan M, Olson K, Spier J (2002) Verification strategies for establishing reliability and validity in qualitative research. Int J Qual Methods 1(2):Article 2
30. Scientific Software Development GmbH (2014) Atlas.ti: qualitative data analysis. http://atlasti.com/. Accessed 20 June 2016
31. Majumdar SR, Johnson JA, McAlister FA, Bellerose D, Russell AS, Hanley DA, Morrish DW, Maksymowych WP, Rowe BH (2008) Multifaceted intervention to improve diagnosis and treatment of osteoporosis in patients with recent wrist fracture: a randomized controlled trial. Can Med Assoc J 178(5):569–575. doi:10.1503/Cmaj.070981
32. Fisher JD, Fisher WA, Shuper PA (2009) The information-motivation-behavioral skills model of HIV preventive behavior. In: Diclemente RJ, Crosby RA, Kegler MC (eds) Emerging theories in health promotion practice and research. Jossey-Bass, San Francisco, CA, pp 21–63
33. Fisher JD, Fisher WA, Amico KR, Harman JJ (2006) An information-motivation-behavioral skills model of adherence to antiretroviral therapy. Health Psychol 25(4):462–473. doi:10.1037/0278-6133.25.4.462
34. Kalichman SC, Rompa D, DiFonzo K, Simpson D, Austin J, Luke W, Kyomugisha F, Buckles J (2001) HIV treatment adherence in women living with HIV/AIDS: research based on the Information-Motivation-Behavioral Skills model of health behavior. J Assoc Nurses AIDS Care 12(4):58–67. doi:10.1016/S1055-3290(06)60217-3
35. Barry MJ, Edgman-Levitan S (2012) Shared decision making—pinnacle of patient-centered care. N Engl J Med 366(9):780–781. doi:10.1056/NEJMp1109283
36. Institute of Medicine (IOM) (2001) Crossing the quality chasm: a new health system for the 21st century Washington. National Academy Press, D.C
37. Kolata G (2016) Osteoporosis drugs shunned for fear of rare side effects. The New York Times, June 2, 2016, p A1
38. Kaufman JD, Bolander ME, Bunta AD, Edwards BJ, Fitzpatrick LA, Simonelli C (2003) Barriers and solutions to osteoporosis care in patients with a hip fracture. J Bone Joint Surg Am 85-A(9):1837–1843
39. Gardner MJ, Brophy RH, Demetrakopoulos D, Koob J, Hong R, Rana A, Lin JT, Lane JM (2005) Interventions to improve osteoporosis treatment following hip fracture. A prospective, randomized trial. J Bone Joint Surg Am 87(1):3–7. doi:10.2106/JBJS.D.02289
40. Meadows LM, Mrkonjic LA, Lagendyk LE, Petersen KM (2004) After the fall: women’s views of fractures in relation to bone health at midlife. Women Health 39(2):47–62. doi:10.1300/J013v39n02_04
41. Sale JE, Gignac MA, Frankel L, Hawker G, Beaton D, Elliot-Gibson V, Bogoch E (2012) Patients reject the concept of fragility fracture—a new understanding based on fracture patients’ communication. Osteoporos Int 23(12):2829–2834. doi:10.1007/s00198-012-1914-0
42. Siris ES, Gehlbach S, Adachi JD, Boonen S, Chapurlat RD, Compston JE, Cooper C, Delmas P, Diez-Perez A, Hooven FH, Lacroix AZ, Netelenbos JC, Pfeilschifter J, Rossini M, Roux C, Saag KG, Sambrook P, Silverman S, Watts NB, Wyman A, Greenspan SL (2011) Failure to perceive increased risk of fracture in women 55 years and older: the Global Longitudinal Study of Osteoporosis in Women (GLOW). Osteoporos Int 22(1):27–35. doi:10.1007/s00198-010-1211-8
43. Sale JE, Beaton DE, Sujic R, Bogoch ER (2010) If it was osteoporosis, I would have really hurt myself. Ambiguity about osteoporosis and osteoporosis care despite a screening programme to educate fragility fracture patients. J Eval Clin Pract 16(3):590–596. doi:10.1111/j.1365-2753.2009.01176.x
44. Majumdar SR (2008) Recent trends in osteoporosis treatment after hip fracture: improving but wholly inadequate. J Rheumatol 35(2):190–192
45. Solomon DH, Iversen MD, Avorn J, Gleeson T, Brookhart MA, Patrick AR, Rekedal L, Shrank WH, Lii J, Losina E, Katz JN (2012) Osteoporosis telephonic intervention to improve medication regimen adherence: a large, pragmatic, randomized controlled trial. Arch Intern Med 172(6):477–483. doi:10.1001/archinternmed.2011.1977
46. Osterberg L, Blaschke T (2005) Adherence to medication. N Engl J Med 353(5):487–497. doi:10.1056/NEJMra050100
47. Sale JE, Gignac MA, Hawker G, Frankel L, Beaton D, Bogoch E, Elliot-Gibson V (2011) Decision to take osteoporosis medication in patients who have had a fracture and are ‘high’ risk for future fracture: a qualitative study. BMC Musculoskelet Disord 12:92. doi:10.1186/1471-2474-12-92
48. Che M, Ettinger B, Liang J, Pressman AR, Johnston J (2006) Outcomes of a disease-management program for patients with recent osteoporotic fracture. Osteoporos Int 17(6):847–854. doi:10.1007/s00198-005-0057-y
49. Miki RA, Oetgen ME, Kirk J, Insogna KL, Lindskog DM (2008) Orthopaedic management improves the rate of early osteoporosis treatment after hip fracture. A randomized clinical trial. J Bone Joint Surg Am 90(11):2346–2353. doi:10.2106/JBJS.G.01246
50. Melo M, Qiu F, Sykora K, Juurlink D, Laupacis A, Mamdani M (2006) Persistence with bisphosphonate therapy in older people. J Am Geriatr Soc 54(6):1015–1016. doi:10.1111/j.1532-5415.2006.00758.x
51. Weiss TW, McHorney CA (2007) Osteoporosis medication profile preference: results from the PREFER-US study. Health Expect 10(3):211–223. doi:10.1111/j.1369-7625.2007.00440.x
52. Ailinger RL, Harper DC, Lasus HA (1998) Bone up on osteoporosis. Development of the facts on osteoporosis quiz. Orthop Nurs 17(5):66–73